Topical nepafenac in the treatment of diabetic macular edema

PURPOSE: To determine the safety and efficacy of topical nepafenac 0.1% in the treatment of diabetic macular edema. METHODS: A consecutive case series was performed of patients treated with nepafenac monotherapy twice daily for diabetic macular edema. Visual acuities (VA) at baseline and final visit...

Descripción completa

Detalles Bibliográficos
Autores principales: Callanan, David, Williams, Patrick
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699803/
https://www.ncbi.nlm.nih.gov/pubmed/19668417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699803/
https://www.ncbi.nlm.nih.gov/pubmed/19668417

Ejemplares similares